The DOI matches its Crossref record; 300 of the 301 references it cites were found in a registry or an index.
Dopamine and Oxytocin Interactions Underlying Behaviors: Potential Contributions to Behavioral Disorders
Open accessAbstract
Dopamine is an important neuromodulator that exerts widespread effects on the central nervous system (CNS) function. Disruption in dopaminergic neurotransmission can have profound effects on mood and behavior and as such is known to be implicated in various neuropsychiatric behavioral disorders including autism and depression. The subsequent effects on other neurocircuitries due to dysregulated dopamine function have yet to be fully explored. Due to the marked social deficits observed in psychiatric patients, the neuropeptide, oxytocin is emerging as one particular neural substrate that may be influenced by the altered dopamine levels subserving neuropathologic‐related behavioral diseases. Oxytocin has a substantial role in social attachment, affiliation and sexual behavior. More recently, it has emerged that disturbances in peripheral and central oxytocin levels have been detected in some patients with dopamine‐dependent disorders. Thus, oxytocin is proposed to be a key neural substrate that interacts with central dopamine systems. In addition to psychosocial improvement, oxytocin has recently been implicated in mediating mesolimbic dopamine pathways during drug addiction and withdrawal. This bi‐directional role of dopamine has also been implicated during some components of sexual behavior. This review will discuss evidence for the existence dopamine/oxytocin positive interaction in social behavioral paradigms and associated disorders such as sexual dysfunction, autism, addiction, anorexia/bulimia, and depression. Preliminary findings suggest that whilst further rigorous testing has to be conducted to establish a dopamine/oxytocin link in human disorders, animal models seem to indicate the existence of broad and integrated brain circuits where dopamine and oxytocin interactions at least in part mediate socio‐affiliative behaviors. A profound disruption to these pathways is likely to underpin associated behavioral disorders. Central oxytocin pathways may serve as a potential therapeutic target to improve mood and socio‐affiliative behaviors in patients with profound social deficits and/or drug addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Anatomically, there is a close relationship between OXT and DA pathways in the brain (Baskerville and Douglas, 2010).”
From Convergence of oxytocin and dopamine signalling in neuronal circuits: Insights into the neurobiology of social interactions across species (2024) · cites this paper as Baskerville and Douglas, 2010
In the citing paper
“Oxytocin may also interact with dopamine to modulate socio-affiliative behaviors and central oxytocin pathways may serve as therapeutic targets to improve mood and social behaviors [168].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [168]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–300 of 300
Role of hypothalamic dopaminergic receptors in the control of lordosis behavior in the female rat
Foreman, M. M., & Moss, R. L. (1979) · Physiology & Behavior · doi:10.1016/0031-9384(79)90088-x · Cited by 81
The Neurobiology of Social Bonds
Kendrick, K. M. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01262.x · Cited by 80
Efferent connections of the hypothalamic “grooming area” in the rat
Roeling, T. A. P., Veening, J. G., Peters, J. P. W., Vermelis, M. E. J., & Nieuwenhuys, R. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90574-y · Cited by 79
Breuer, M. E., Groenink, L., Oosting, R. S., Buerger, E., Korte, S. M., Ferger, B., & Olivier, B. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.029 · Cited by 78
Hippocampal oxytocin mediates apomorphine-induced penile erection and yawning
Melis, M. R., Stancampiano, R., & Argiolas, A. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90447-n · Cited by 78
Neurochemical interactions of cocaine with dopaminergic systems
Galloway, M. P. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90137-x · Cited by 77
Neurobiology of human affiliative behaviour: implications for psychiatric disorders
Bora, E., Yücel, M., & Allen, N. B. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328329e970 · Cited by 75
Opioid tolerance and dependence in the magnocellular oxytocin system: a physiological mechanism?
Ja, R., Leng, G., & Bicknell, R. (1995) · Experimental Physiology · doi:10.1113/expphysiol.1995.sp003850 · Cited by 75
Dopamine D2 receptor activation depolarizes rat supraoptic neurones in hypothalamic explants.
Yang, C. R., Bourque, C. W., & Renaud, L. P. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018840 · Cited by 75
Anti-relapse medications: Preclinical models for drug addiction treatment
Yahyavi-Firouz-Abadi, N., & See, R. (2009) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2009.06.014 · Cited by 74
Kim, S., & Webster, M. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.151 · Cited by 73
Melis, M. R., Succu, S., Sanna, F., Boi, A., & Argiolas, A. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06912.x · Cited by 72
A systematic review of long-term studies of drug treated and non-drug treated depression
Hughes, S., & Cohen, D. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.027 · Cited by 71 · cited 1×
“Since the current main drug treatment for depression, selective serotonin reuptake inhibitors, is not effective in a large majority of patients or has only a delayed effect in ameliorating symptoms [301], perhaps the interaction between oxytocin-serotonin, or oxytocin–dopamine-serotonin could be exploited further in d…”
BackgroundCarson, C. C., Hatzichristou, D. G., A., C. S., Lording, D. W., Lyngdorf, P., Aliotta, P. J., Auerbach, S., Murdock, M. I., Wilkins, H. J., McBride, T. A., et al. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2004.05161.x · Cited by 70
Melanocortins in the Treatment of Male and Female Sexual Dysfunction
Hallam, T. J., Spana, C., Earle, D. C., Shadiack, A. M., & Sharma, S. D. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780906681 · Cited by 70
Melis, M. R., Succu, S., Iannucci, U., & Argiolas, A. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(97)00002-5 · Cited by 69
Neuropeptides in Hypothalamic Neuronal Disorders
Swaab, D. F. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)40003-5 · Cited by 69
Succu, S., Sanna, F., Cocco, C., Melis, T., Boi, A., Ferri, G., Argiolas, A., & Melis, M. R. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06385.x · Cited by 69
First‑line pharmacotherapies for depression – what is the best choice?
Koenig, A. M., & Thase, M. E. (2009) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.743 · Cited by 69
Clemens, K. J., Cornish, J. L., Hunt, G. E., & McGregor, I. S. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.06.004 · Cited by 68
Uvnäs‐Moberg, K., Alster, P., & Svensson, T. H. (1992) · Psychopharmacology · doi:10.1007/bf02247726 · Cited by 68
Lonstein, J. S. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00952-8 · Cited by 68
Motherhood in Human and Nonhuman Primates: Biosocial Determinants
Skuse, D. (1995) · UCL Discovery (University College London) · Cited by 66
Sarnyai, Z., Vecsernyés, M., Laczi, F., Bíró, É., Szabó, G., & Kovács, G. L. (1992) · Neuropeptides · doi:10.1016/0143-4179(92)90006-i · Cited by 66
Regulation of male rat copulatory behavior by preoptic incertohypothalamic dopamine neurons
Bitran, D., Hull, E. M., Holmes, G. M., & Lookingland, K. J. (1988) · Brain Research Bulletin · doi:10.1016/0361-9230(88)90062-7 · Cited by 66
Neurophysiology/pharmacology of erection
Andersson, K.-E. (2001) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900718 · Cited by 63
Pfaus, J. G., Jakob, A., Kleopoulos, S. P., Gibbs, R. B., & Pfaff, D. W. (2008) · Neuroendocrinology · doi:10.1159/000126760 · Cited by 62
Schulze, H. G., & Gorzalka, B. B. (1991) · Neuropeptides · doi:10.1016/0143-4179(91)90008-7 · Cited by 60
Kavelaars, A., Cobelens, P. M., Teunis, M., & Heijnen, C. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.004 · Cited by 58
Caquineau, C., Leng, G., Guan, X.-M., Jiang, M., der Ploeg, L. H. T. V., & Douglas, A. J. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01465.x · Cited by 58
Self-citationKita, I., Yoshida, Y., & Nishino, S. (2006) · Neuroscience Research · doi:10.1016/j.neures.2005.12.005 · Cited by 55
Mason, W. T. (1983) · Brain Research · doi:10.1016/0006-8993(83)91044-2 · Cited by 55
Ariano, M. A., Monsma, F. J., Barton, A. C., Kang, H., Haugland, R. P., & Sibley, D. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8570 · Cited by 54
Clément, P., Peeters, M., Bernabé, J., Denys, P., Alexandre, L., & Giuliano, F. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.176 · Cited by 53
Melis, M. R., Succu, S., Mascia, M. S., & Argiolas, A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.12.053 · Cited by 52
Oxytocin and neuroadaptation to cocaine
Sarnyai, Z. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61587-3 · Cited by 51
Sermasi, E., & Coote, J. H. (1994) · Brain Research · doi:10.1016/0006-8993(94)91331-5 · Cited by 51
Safarinejad, M. R., & Hosseini, S. Y. (2008) · The Journal of Urology · doi:10.1016/j.juro.2007.10.063 · Cited by 51
Effect of apomorphine on oxytocin concentrations in different brain areas and plasma of male rats
Melis, M., Argiolas, A., Stancampiano, R., & Gessa, G. L. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90497-t · Cited by 50
The effect of selective D1 and D2 dopaminergic agents on sexual receptivity in the female rat
Grierson, J. P., James, M. D., Pearson, J. R., & Wilson, C. A. (1988) · Neuropharmacology · doi:10.1016/0028-3908(88)90169-4 · Cited by 49
Douglas, A. J. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80014-8 · Cited by 48
Self-citationKashon, M. L., Arbogast, J. A., & Sisk, C. L. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961223)376:4 · Cited by 48
Sanghera, M. K., Anselmo-Franci, J. A., & McCann, S. M. (2008) · Neuroendocrinology · doi:10.1159/000125931 · Cited by 47
Melis, M. R., Succu, S., Sanna, F., Melis, T., Mascia, M. S., Enguehard‐Gueiffier, C., Hübner, H., Gmeiner, P., Gueiffier, A., & Argiolas, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05043.x · Cited by 46
Oral Treatment of Erectile Dysfunction with Apomorphine SL
Altwein, J. E., & Keuler, F. U. (2001) · Urologia Internationalis · doi:10.1159/000051001 · Cited by 45
Guevara‐Guzmán, R., Arriaga, V., Kendrick, K. M., Bernal, C., Vega, X., Mercado-Gómez, O. F., & Rivas-Arancibia, S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.047 · Cited by 44
Ückert, S., Becker, A. J., Ness, B. O., Stief, C. G., Scheller, F., Knapp, W. H., & Udo Jonas, A. (2003) · World Journal of Urology · doi:10.1007/s00345-002-0300-5 · Cited by 43
ZHANG, X. H., Filippi, S., Vignozzi, L., Morelli, A., Mancina, R., Luconi, M., Donati, S., Marini, M., Vannelli, G. B., Forti, G., et al. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05885 · Cited by 42
Ludwig, M., Sabatier, N., Dayanithi, G., Russell, J. A., & Leng, G. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39021-6 · Cited by 39
Oxytocin enhances, and oxytocin antagonism decreases, sexual receptivity in intact female rats
Benelli, A., Poggioli, R., Luppi, P., Ruini, L., Bertolini, A., & Arletti, R. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90005-1 · Cited by 39
Apomorphine: Facilitation of sexual behaviour in female rats
Hamburger-Bar, R., & Rigter, H. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90304-0 · Cited by 39
Smoking Cessation Interventions in Clinical Practice
Cornuz, J. (2007) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2007.06.009 · Cited by 38
Cardiac sympatho-excitatory action of PVN-spinal oxytocin neurones
Yang, Z. R., Han, D., & Coote, J. H. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2009.01.013 · Cited by 37
Eriksson, J. G., Olausson, B., & Jankowska, E. (1996) · Experimental Brain Research · doi:10.1007/bf00227307 · Cited by 37
Relationship of oxytocin pathways to the control of neuroendocrine and autonomic function
Sawchenko, P. E., & Swanson, L. W. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90685-x · Cited by 35
Examination of association to autism of common genetic variationin genes related to dopamine
Anderson, B. M., Schnetz‐Boutaud, N. C., Bartlett, J., Wright, H. H., Abramson, R. K., Cuccaro, M. L., Gilbert, J. R., Pericak‐Vance, M. A., & Haines, J. L. (2008) · Autism Research · doi:10.1002/aur.55 · Cited by 34
Eliasson, M., & Meyerson, B. J. (1976) · Psychopharmacology · doi:10.1007/bf00426833 · Cited by 34
Brown, C. H., & Russell, J. A. (2004) · Stress · doi:10.1080/10253890410001727776 · Cited by 34
Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.
Krüger, S., & Kennedy, S. H. (2000) · PubMed Central · Cited by 34
Sullivan, R. M. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1301.013 · Cited by 34
Lundberg, P. O., Erteki̇n, C., Ghezzi, A., Swash, M., & Vodusek, D. B. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.0080s3002.x · Cited by 32
Immunotoxic catecholamine lesions attenuate 2DG-induced increase of AGRP mRNA
Fraley, G. S., Dinh, T. T. N., & Ritter, S. (2002) · Peptides · doi:10.1016/s0196-9781(02)00044-x · Cited by 31
Centrally Acting Mechanisms for the Treatment of Male Sexual Dysfunction
Miner, M. M., & Seftel, A. D. (2007) · Urologic Clinics of North America · doi:10.1016/j.ucl.2007.08.008 · Cited by 30
Risperidone-Induced Enuresis in Two Children with Autistic Disorder
Hergüner, S., & Mukaddes, N. M. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0056 · Cited by 29
The elusive etiology of autism: nature and nurture?
Strathearn, L. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.011.2009 · Cited by 29
Keeping oxytocin neurons under control during stress in pregnancy
Brunton, P. J., & Russell, J. A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00430-5 · Cited by 28
Increased Vulnerability to Stress Following Opiate Exposures: Behavioral and Autonomic Correlates.
Blatchford, K. E., Diamond, K., Westbrook, R. F., & McNally, G. P. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.4.1034 · Cited by 27
AVP- and OT-neurophysins response to apomorphine and clonidine in major depression
Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.015 · Cited by 26
Social anxiety disorder: epidemiology, biology and treatment.
Fink, M., Akimova, E., Spindelegger, C., Hahn, A., Lanzenberger, R. R., & Kasper, S. F. (2009) · PubMed · Cited by 25
Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride
Lü, W., Jiang, W., Chen, J., Yin, M., Wang, Z., & Jiang, X. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.012 · Cited by 22
Behavioral response to methylphenidate challenge: Influence of early life parental care
Engert, V., Joober, R., Meaney, M. J., Hellhammer, D. H., & Pruessner, J. C. (2009) · Developmental Psychobiology · doi:10.1002/dev.20380 · Cited by 21
Location and molecular cloning of D1 dopamine receptor
Gingrich, J. A., Dearry, A., Falardeau, P., Bates, M. D., Fremeau, R. T., & Caron, M. G. (1992) · Neurochemistry International · doi:10.1016/0197-0186(92)90204-5 · Cited by 21
Clinical applications of centrally acting agents in male sexual dysfunction
Hellstrom, W. J. G. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.18 · Cited by 20
Quysner, A., & Blaustein, J. D. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03116-x · Cited by 20
Wirth, M. M., Olszewski, P. K., Levine, A. S., & Giraudo, S. Q. (2002) · Neuroreport · doi:10.1097/00001756-200207190-00028 · Cited by 20
Cameron, J. L., Pomerantz, S., Layden, L. M., & Amico, J. A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1355489 · Cited by 20
Effects of D2-dopaminergic receptor stimulation on the lordotic response of female rats
Foreman, M. M., & Hall, J. L. (1987) · Psychopharmacology · doi:10.1007/bf00690934 · Cited by 19
Skoog, B., & Noga, B. R. (1995) · Experimental Brain Research · doi:10.1007/bf00242180 · Cited by 18
(2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05756.x · Cited by 18
Ralph, D. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80044-4 · Cited by 17
Clinical screening for obsessive-compulsive and related disorders.
Fineberg, N. A., Krishnaiah, R., Moberg, J., & O'Doherty, C. (2008) · PubMed · Cited by 17
Blaustein, J. D. (2009) · Endocrinology · doi:10.1210/en.2009-1308 · Cited by 17
Erectile dysfunction: clinical guidelines (1).
Safarinejad, M. R., & Hosseini, S. (2004) · Urology journal./Urology jornal. · Cited by 15
Examination of tetrahydrobiopterin pathway genes in autism
Schnetz‐Boutaud, N. C., Anderson, B. M., Brown, K. D., Wright, H. H., Abramson, R. K., Cuccaro, M. L., Gilbert, J. R., Pericak‐Vance, M. A., & Haines, J. L. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00521.x · Cited by 15
Melis, M. R., Stancampiano, R., & Argiolas, A. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90009-s · Cited by 14
Comparative cross‐over study of sildenafil and apomorphine for treating erectile dysfunction
Afif‐Abdo, J., Telöken, C., Damião, R., Koff, W. J., Wroclawski, E. R., Yamasaki, R., Torres, L. O., Sabaneeff, J., Faria, G. E., Pompeo, A. C. L., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07767.x · Cited by 13
Treatment of erectile dysfunction
Dinsmore, W. W. (2004) · International Journal of STD & AIDS · doi:10.1258/095646204773557721 · Cited by 13
Nonpharmacologic treatment of erectile dysfunction.
Montague, D. K. (2002) · PubMed · Cited by 12
Intranasal apomorphine. Nastech Pharmaceutical.
Kendirci, M., & Hellstrom, W. J. G. (2004) · PubMed · Cited by 12
Multiple dopamine receptors: The D3 receptor and actions of substances of abuse
Schwartz, J., Díaz, J., Griffon, N., Lévesque, D., Martres, M., & Sokoloff, P. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7330-7_9 · Cited by 10
Neurosexology. Guidelines for neurologists.
Lundberg, P. O., Erteki̇n, C., Ghezzi, A., Swash, M., & Vodušek, D. B. (2001) · Cited by 9
Neue Therapieoptionen zur Behandlung der erektilen Dysfunktion
Sperling, H. V., Lümmen, G., Schneider, T., & Rubben, H. (2003) · Herz · doi:10.1007/s00059-003-2472-1 · Cited by 9
Central oxytocinergic and dopaminergic mechanisms regulating penile erection in conscious rats
Martino, B. R., Hsieh, G. C., Hollingsworth, P. R., Mikusa, J. P., Moreland, R. B., & Bitner, R. S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.06.003 · Cited by 9
Reinforcement Pathways for Cocaine
Koob, G. F., & Hubner, C. B. (1988) · PsycEXTRA Dataset · doi:10.1037/e496572006-010 · Cited by 8
Rat model of erectile dysfunction caused by cavernous nerve ablation.
Zhang, X., Hu, L., Yin, J., Mo, Z., & Chen, J. (2002) · PubMed · Cited by 8
Depression and effects of antidepressant drugs on the stress systems
(2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80059-8 · Cited by 6
[Study of dopamine transporter imaging on the brain of children with autism].
Sun, X.-M., Jing, Y., & Zheng, C. (2008) · PubMed · Cited by 6
New treatment options for erectile dysfunction.
Cg, M. (1999) · PubMed · Cited by 5
[Apomorphine and erectile dysfunction].
Tan, D., Yao, Y., & Zhang, J. (2007) · PubMed · Cited by 1
Matelli (1998) · doi:10.1002/(sici)1096-9861(19981221)402:3
Research works printed but not linked: 13
- 10.1016/0306-4522(93)90285-N · DOI · Paper page
- 10.1210/jc.75.3.855 · DOI
- Kendirci M, 2004, Intranasall apomorphine Nastech pharmaceutical, Idrugs, 7, 483
- 10.1038/35053579 · DOI · Paper page
- Everitt BJ, 1998, Differential induction of C‐FOS in limbic and hypothalamic structures by primary and secondary reinforcers, Eur J Neurosci, 10, 157
- 10.1038/35053579 · DOI · Paper page
- 10.1016/0028-3908(90)90095-9 · DOI · Paper page
- 10.1016/0306-4530(94)90062-0 · DOI
- 10.1016/j.physbeh.2007.04.012 · DOI
- 10.1016/j.physbeh.2007.04.012 · DOI
- Leng G, 2009, The handbook of behaviour, diet and nutrition
- Ingram CD, 2005, Techniques in the behavioural and neural sciences series, 609
- 10.1016/j.pbb.2008.07.002 · DOI
Cited by
Sorted by citations
Brand, M., Young, K. S., Laier, C., Wölfling, K., & Potenza, M. N. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.033 · Cited by 2,416
“One biological correlate of insecure attachment style is lower evels of oxytocin, which have also been associated with developng addictive behaviors (Baskerville and Douglas, 2010; Sarnyai and ovács, 2014).”
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999
“In rats, OXTergic and dopaminergic fibers often exist in close apposition to each other (129), with dopamine D2 receptors being expressed directly on OXT neurons (61), suggesting a close interaction between OXT and dopamine systems (62).”
BackgroundThe Social Salience Hypothesis of Oxytocin
Shamay-Tsoory, S. G., & Abu-Akel, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.020 · Cited by 904
“key regions within this system [for reviews see (6, 97-99)].”
Consensus Paper: Pathological Role of the Cerebellum in Autism
Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., Chauhan, A., Chauhan, V., Dager, S. R., Dickson, P. E., et al. (2012) · The Cerebellum · doi:10.1007/s12311-012-0355-9 · Cited by 723
“Oxytocin may also interact with dopamine to modulate socio-affiliative behaviors and central oxytocin pathways may serve as therapeutic targets to improve mood and social behaviors [168].”
BackgroundBiased Oxytocinergic Modulation of Midbrain Dopamine Systems
Xiao, L., Priest, M. F., Nasenbeny, J., Lu, T., & Kozorovitskiy, Y. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.003 · Cited by 292
Metadata
- Authors
- Baskerville, T. A., & Douglas, A. J.
- Affiliations
- University of Glasgow (GB)
- University of Edinburgh (GB)
- Corresponding author
- Baskerville, Tracey A.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2010-05-06
- Volume
- 16
- Issue
- 3
- Pages
- e92-123
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- PMC
- PMC6493805
- OpenAlex
- W1556392272
- Cited by
- 377
- References
- 301
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 30 · 2023: 15 · 2022: 19 · 2021: 39 · 2020: 23 · 2019: 29 · 2018: 21 · 2017: 26 · 2016: 26 · 2015: 19 · 2014: 22 · 2013: 28 · 2012: 22
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- CNS Neuroscience & Therapeutics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Pfizer
- Wellcome Trust
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- dopamine, oxytocin, social behavior, autism spectrum disorder, depression, drug addiction, anorexia nervosa, bulimia nervosa, sexual dysfunction, mesolimbic dopamine system, social attachment
- MeSH terms
- Animals, Behavior, Behavior, Animal, Behavioral Symptoms, Central Nervous System, Dopamine, Female, Humans, Male, Neurochemistry, Oxytocin, Pair Bond, Receptors, Dopamine, Sexual Behavior, Social Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review